Advances in clinical research on hypoglycemia after bariatric metabolic surgery
10.3760/cma.j.cn.115807-20230719-00012
- VernacularTitle:关注减重代谢手术后低血糖的临床诊治
- Author:
Huaijun ZHENG
1
;
Huijuan ZHU
Author Information
1. 中国医学科学院，北京协和医学院，北京协和医院内分泌科，国家卫生健康委员会内分泌重点实验室，疑难重症及罕见病国家重点实验室，北京 100730
- Keywords:
Obesity;
Bariatric metabolic surgery;
Hypoglycemia
- From:
Chinese Journal of Endocrine Surgery
2023;17(6):641-644
- CountryChina
- Language:Chinese
-
Abstract:
Obesity has emerged as a significant public health concern with profound implications for human well-being. Bariatric metabolic surgery can significantly reduce the weight of patients with severe obesity and improve the related complications, and has been widely used in clinical practice. With the growth of surgical amount, the occurrence of postoperative hypoglycemia, in addition to surgery-related adverse events, has gradually attracted clinical attention. Post-bariatric hypoglycemia (PBH) occurs 6-12 months after bariatric metabolic surgery. It is characterized by blood glucose levels ≤2.8~3.3 mmol/L within 1-3 hours after a meal, accompanied by symptoms of sympathetic nervous system activation and even neuroglycopenic symptoms. Limited epidemiological investigations suggest that the prevalence of PBH ranges from 0.2% to 44.2%. Notably, severe and recurrent hypoglycemic events have deleterious implications for patients, significantly compromising their quality of life and posing a potential threat to their life safety. Consequently, the management of PBH warrants comprehensive clinical attention.
